Adherence to Urate-Lowering Therapy Associated With Lower Risk for Cardiovascular Disease in Patients With Gout – Rheumatology Advisor

Patients with gout, especially those aged younger than 65 years and men, receiving treatment with urate-lowering therapy (ULT) are less likely to develop cardiovascular disease (CVD) if they had an adherence rate of at least 0.7, according to study results…

Click here to view the original article.